PTEN Negatively Regulates MAPK Signaling during Vulval Development

English version České info

Vulval development in Caenorhabditis elegans serves as an excellent model to examine the crosstalk between different conserved signaling pathways that are deregulated in human cancer. The concerted action of the RAS/MAPK, NOTCH, and WNT pathways determines an invariant pattern of cell fates in three vulval precursor cells. We have discovered a novel form of crosstalk between components of the Insulin and the RAS/MAPK pathways. The insulin receptor DAF-2 stimulates, while DAF-18 PTEN inhibits, RAS/MAPK signaling in the vulval precursor cells. Surprisingly, the inhibitory activity of DAF-18 PTEN on the RAS/MAPK pathway is partially independent of its PIP₃ lipid phosphatase activity and does not involve further downstream components of the insulin pathway, such as AKT and DAF-16 FOXO. Genetic and biochemical analyses indicate that DAF-18 negatively regulates vulval induction by inhibiting MAPK activation. Thus, mutations in the PTEN tumor suppressor gene may result in the simultaneous hyper-activation of two oncogenic signaling pathways.

Vyšlo v časopise: PTEN Negatively Regulates MAPK Signaling during Vulval Development. PLoS Genet 8(8): e32767. doi:10.1371/journal.pgen.1002881
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002881

Souhrn

Zdroje

1. LiJ, YenC, LiawD, PodsypaninaK, BoseS, et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943–1947.

2. BlumenthalGM, DennisPA (2008) PTEN hamartoma tumor syndromes. Eur J Hum Genet 16: 1289–1300 doi:10.1038/ejhg.2008.162.

3. LiawD, MarshDJ, LiJ, DahiaPL, WangSI, et al. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16: 64–67 doi:10.1038/ng0597-64.

4. MyersM, PassI, BattyI, Van der KaayJ, StolarovJ, et al. (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 95: 13513–13518.

5. DeyN, CrosswellHE, DeP, ParsonsR, PengQ, et al. (2008) The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Cancer Res 68: 1862–1871 doi:10.1158/0008-5472.CAN-07-1182.

6. CaiX-M, TaoB-B, WangL-Y, LiangY-L, JinJ-W, et al. (2005) Protein phosphatase activity of PTEN inhibited the invasion of glioma cells with epidermal growth factor receptor mutation type III expression. Int J Cancer 117: 905–912 doi:10.1002/ijc.21251.

7. MyersMP, StolarovJP, EngC, LiJ, WangSI, et al. (1997) P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94: 9052–9057.

8. TamuraM, GuJ, MatsumotoK, AotaS, ParsonsR, et al. (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280: 1614–1617.

9. GildeaJ, HerlevsenM, HardingM, GuldingK, MoskalukC, et al. (2004) PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Oncogene 23: 6788–6797 doi:10.1038/sj.onc.1207599.

10. GuJ, TamuraM, PankovR, DanenEH, TakinoT, et al. (1999) Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 146: 389–403.

11. HuPJ (2007) Dauer. Worm Book 1–19 doi:10.1895/wormbook.1.144.1.

12. ChristensenR, la Torre-Ubieta deL, BonniA, Colón-RamosDA (2011) A conserved PTEN/FOXO pathway regulates neuronal morphology during C. elegans development. Development 138: 5257–5267 doi:10.1242/dev.069062.

13. FukuyamaM, RougvieA, RothmanJ (2006) C. elegans DAF-18/PTEN mediates nutrient-dependent arrest of cell cycle and growth in the germline. Curr Biol 16: 773–779 doi:10.1016/j.cub.2006.02.073.

14. MihaylovaV, BorlandC, ManjarrezL, SternM, SunH (1999) The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway. Proc Natl Acad Sci USA 96: 7427–7432.

15. SolariF, Bourbon-PiffautA, MasseI, PayrastreB, ChanA, et al. (2005) The human tumour suppressor PTEN regulates longevity and dauer formation in Caenorhabditis elegans. Oncogene 24: 20–27 doi:10.1038/sj.onc.1207978.

16. ParadisS, RuvkunG (1998) Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev 12: 2488–2498.

17. CahillCM, TzivionG, NasrinN, OggS, DoreJ, et al. (2001) Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways. J Biol Chem 276: 13402–13410 doi:10.1074/jbc.M010042200.

18. BrisbinS, LiuJ, BoudreauJ, PengJ, EvangelistaM, et al. (2009) A role for C. elegans Eph RTK signaling in PTEN regulation. Dev Cell 17: 459–469 doi:10.1016/j.devcel.2009.08.009.

19. SuzukiY, HanM (2006) Genetic redundancy masks diverse functions of the tumor suppressor gene PTEN during C. elegans development. Genes Dev 20: 423–428 doi:10.1101/gad.1378906.

20. SternbergPW (2005) Vulval development. Worm Book 1–28 doi:10.1895/wormbook.1.6.1.

21. BattuG, HoierE, HajnalA (2003) The C. elegans G-protein-coupled receptor SRA-13 inhibits RAS/MAPK signalling during olfaction and vulval development. Development 130: 2567–2577.

22. ZouW, LuQ, ZhaoD, LiW, MapesJ, et al. (2009) Caenorhabditis elegans myotubularin MTM-1 negatively regulates the engulfment of apoptotic cells. PLoS Genet 5: e1000679 doi:10.1371/journal.pgen.1000679.

23. AshrafiK, ChangFY, WattsJL, FraserAG, KamathRS, et al. (2003) Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421: 268–272 doi:10.1038/nature01279.

24. KinchenJM, DoukoumetzidisK, AlmendingerJ, StergiouL, Tosello-TrampontA, et al. (2008) A pathway for phagosome maturation during engulfment of apoptotic cells. Nat Cell Biol 10: 556–566 doi:10.1038/ncb1718.

25. BurdineRD, BrandaCS, SternMJ (1998) EGL-17(FGF) expression coordinates the attraction of the migrating sex myoblasts with vulval induction in C. elegans. Development 125: 1083–1093.

26. BersetT, HoierE, BattuG, CanevasciniS, HajnalA (2001) Notch inhibition of RAS signaling through MAP kinase phosphatase LIP-1 during C. elegans vulval development. Science 291: 1055–1058 doi:10.1126/science.1055642.

27. LacknerMR, KimSK (1998) Genetic analysis of the Caenorhabditis elegans MAP kinase gene mpk-1. Genetics 150: 103–117.

28. ChangC, HopperN, SternbergP (2000) Caenorhabditis elegans SOS-1 is necessary for multiple RAS-mediated developmental signals. EMBO J 19: 3283–3294 doi:10.1093/emboj/19.13.3283.

29. TanPB, LacknerMR, KimSK (1998) MAP kinase signaling specificity mediated by the LIN-1 Ets/LIN-31 WH transcription factor complex during C. elegans vulval induction. Cell 93: 569–580.

30. SasaokaT, KobayashiM (2000) The functional significance of Shc in insulin signaling as a substrate of the insulin receptor. Endocr J 47: 373–381.

31. SasaokaT, DrazninB, LeitnerJW, LangloisWJ, OlefskyJM (1994) Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. J Biol Chem 269: 10734–10738.

32. NanjiM, HopperN, GemsD (2005) LET-60 RAS modulates effects of insulin/IGF-1 signaling on development and aging in Caenorhabditis elegans. Aging Cell 4: 235–245 doi:10.1111/j.1474-9726.2005.00166.x.

33. CuiM, ChenJ, MyersTR, HwangBJ, SternbergPW, et al. (2006) SynMuv Genes Redundantly Inhibit lin-3/EGF Expression to Prevent Inappropriate Vulval Induction in C. elegans. Dev Cell 10: 667–672 doi:10.1016/j.devcel.2006.04.001.

34. PlanchonSM, WaiteKA, EngC (2008) The nuclear affairs of PTEN. J Cell Sci 121: 249–253 doi:10.1242/jcs.022459.

35. WengLP, BrownJL, EngC (2001) PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum Mol Genet 10: 599–604.

36. HongY, RoyR, AmbrosV (1998) Developmental regulation of a cyclin-dependent kinase inhibitor controls postembryonic cell cycle progression in Caenorhabditis elegans. Development 125: 3585–3597.

37. BrennerS (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71–94.

38. HobertO (2002) PCR fusion-based approach to create reporter gene constructs for expression analysis in transgenic C. elegans. Bio Techniques 32: 728–730.

39. MelloCC, KramerJM, StinchcombD, AmbrosV (1991) Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J 10: 3959–3970.

40. SternbergPW, HorvitzHR (1986) Pattern formation during vulval development in C. elegans. Cell 44: 761–772.

41. KamathRS, FraserAG, DongY, PoulinG, DurbinR, et al. (2003) Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421: 231–237 doi:10.1038/nature01278.

42. AbramoffMD, MagalhãesPJ, RamSJ (2004) Image processing with ImageJ. Biophotonics international 11: 36–42.